Literature DB >> 33429829

Impact of the numbers of injections of platelet rich plasma on the clinical outcomes in patients with knee osteoarthritis: A protocol for an updated network meta-analysis.

Pan Wang1, Kai Li1, Zuxin Jiang1, Beiming Qiu1, Cheng Nie1, Hongsheng Luo1, Zhengjiang Li2.   

Abstract

BACKGROUND: Two published meta-analyses have investigated the effects of the number of injections of platelet rich plasma (PRP) on clinical outcomes in knee osteoarthritis patients, however conflicting findings were generated.
METHODS: We will systematically search PubMed, Embase, and China National Knowledgement Infrastructure (CNKI) to capture additional eligible studies. After screening citations, extracting essential data, assessing the risk of bias, we will use RevMan software and Open BUGS to perform head-to-head and network meta-analysis of pain alleviation and improvement of joint functionality, respectively. DISCUSSION: Knee joint osteoarthritis (KOA) is the main cause of joint degeneration in elderly, which seriously reduces patients quality of life. Although intra-articular PRP has been extensively prescribed to treat KOA, a definitive conclusion about the appropriate number of injections has not yet been generated in published meta-analyses. The present updated network meta-analysis will comprehensively answer this question. ETHICS AND DISSEMINATION: We will communicate our findings through participating in academic conferences or submiting it to be considered for publication in peer reviewed scholar journal. INPLASY REGISTRATION NUMBER: We registered this protocol in International Plateform of Registered Systematic Review and Meta-Analysis Protocols (INPLASY) platform and obtained an identifier of INPLASY2020110043 (https://inplasy.com/inplasy-2020-11-0043/).
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 33429829      PMCID: PMC7793368          DOI: 10.1097/MD.0000000000024250

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  49 in total

1.  Intraarticular injection of platelet-rich plasma in knee osteoarthritis: single versus triple application approach. Pilot study.

Authors:  Mario Simental-Mendía; Carlos Alberto Acosta-Olivo; Alejandra Nohemí Hernández-Rodríguez; Oscar Rubén Santos-Santos; Santiago de la Garza-Castro; Víctor Manuel Peña-Martínez; Félix Vilchez-Cavazos
Journal:  Acta Reumatol Port       Date:  2019 Apr-Jun       Impact factor: 1.290

Review 2.  Does Intra-articular Platelet-Rich Plasma Injection Provide Clinically Superior Outcomes Compared With Other Therapies in the Treatment of Knee Osteoarthritis? A Systematic Review of Overlapping Meta-analyses.

Authors:  Kirk A Campbell; Bryan M Saltzman; Randy Mascarenhas; M Michael Khair; Nikhil N Verma; Bernard R Bach; Brian J Cole
Journal:  Arthroscopy       Date:  2015-05-29       Impact factor: 4.772

Review 3.  The efficacy of platelet-rich plasma in the treatment of symptomatic knee osteoarthritis: a systematic review with quantitative synthesis.

Authors:  Amir Khoshbin; Timothy Leroux; David Wasserstein; Paul Marks; John Theodoropoulos; Darrell Ogilvie-Harris; Rajiv Gandhi; Kirat Takhar; Grant Lum; Jaskarndip Chahal
Journal:  Arthroscopy       Date:  2013-12       Impact factor: 4.772

4.  The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.

Authors:  Julian P T Higgins; Douglas G Altman; Peter C Gøtzsche; Peter Jüni; David Moher; Andrew D Oxman; Jelena Savovic; Kenneth F Schulz; Laura Weeks; Jonathan A C Sterne
Journal:  BMJ       Date:  2011-10-18

5.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.

Authors:  David Moher; Larissa Shamseer; Mike Clarke; Davina Ghersi; Alessandro Liberati; Mark Petticrew; Paul Shekelle; Lesley A Stewart
Journal:  Syst Rev       Date:  2015-01-01

6.  Randomized controlled trial comparing hyaluronic acid, platelet-rich plasma and the combination of both in the treatment of mild and moderate osteoarthritis of the knee.

Authors:  José F S D Lana; Adam Weglein; Steve E Sampson; Eduardo F Vicente; Stephany Cares Huber; Clarissa V Souza; Mary A Ambach; Hunter Vincent; Aline Urban-Paffaro; Carolina M K Onodera; Joyce M Annichino-Bizzacchi; Maria Helena A Santana; William D Belangero
Journal:  J Stem Cells Regen Med       Date:  2016-11-29

7.  Single- and double-dose of platelet-rich plasma versus hyaluronic acid for treatment of knee osteoarthritis: A randomized controlled trial.

Authors:  Mehdi Tavassoli; Nasser Janmohammadi; Akram Hosseini; Soraya Khafri; Seyed Mokhtar Esmaeilnejad-Ganji
Journal:  World J Orthop       Date:  2019-09-18

8.  Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial.

Authors:  X Chevalier; J Jerosch; P Goupille; N van Dijk; F P Luyten; D L Scott; F Bailleul; K Pavelka
Journal:  Ann Rheum Dis       Date:  2010-01       Impact factor: 19.103

9.  Platelet-rich plasma versus hyaluronic acid in the treatment of knee osteoarthritis: A meta-analysis.

Authors:  Zehan Chen; Chang Wang; Di You; Shishun Zhao; Zhe Zhu; Meng Xu
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.889

10.  PRP Injections for the Treatment of Knee Osteoarthritis: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Giuseppe Filardo; Davide Previtali; Francesca Napoli; Christian Candrian; Stefano Zaffagnini; Alberto Grassi
Journal:  Cartilage       Date:  2020-06-19       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.